Previous studies have shown that Tregs expressing CD39 inhibited the antitumor immunity mediated by NK cells (14) and that anti-CD38 antibodies decreased Tregs’ suppression and restored CD4+CD25- T cell proliferation in multiple myeloma by decreasing the percentage of CD38 expression (15). This evidence concerns the gene CD38 and plasma cell myeloma.